Mitochondrial Dysfunction in the Cardio-Renal Axis

Area of Science:

• Mitochondrial biology
• Cardiovascular medicine
• Nephrology

Background:

• Cardiovascular disease (CVD) often complicates chronic kidney disease (CKD), leading to cardio-renal syndrome (CRS).
• Patients with both conditions face a 20% to 500% increased risk of all-cause mortality.
• Mitochondrial dysfunction is implicated in both cardiovascular and renal pathologies.

Purpose of the Study:

• To review the role of mitochondrial homeostasis malfunction in CRS.
• To explore how mitochondrial dysfunction contributes to vascular pathologies in CKD and vice versa.
• To guide the development of novel therapeutic strategies for CRS.

Main Methods:

• Literature review of preclinical studies.
• Analysis of mitochondrial homeostasis pathways: biogenesis, dynamics, oxidative stress, and mitophagy.
• Examination of the interplay between kidney injury and vascular pathologies.

Main Results:

• Mitochondrial dysfunction is a central mechanism in CRS development and progression.
• Impaired mitochondrial biogenesis, dynamics, oxidative stress, and mitophagy contribute to vascular damage.
• Understanding these mechanisms offers insights into therapeutic interventions.

Conclusions:

• Maintaining mitochondrial homeostasis is a promising therapeutic strategy for CRS.
• Targeting mitochondrial pathways may mitigate the adverse effects of cardio-renal interactions.
• Further research into mitochondrial mechanisms can inform novel CRS treatments.